Structure-function studies of T-cell receptor-superantigen interactions.

scientific article published in June 1998

Structure-function studies of T-cell receptor-superantigen interactions. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1600-065X.1998.TB01196.X
P698PubMed publication ID9700510

P50authorHongmin LiQ54438185
P2093author name stringR A Mariuzza
A Llera
P2860cites workCrystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding siteQ27729723
Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigenQ27731278
An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complexQ27733448
Structure of the complex between human T-cell receptor, viral peptide and HLA-A2Q27733853
Crystal structure of a T-cell receptor beta-chain complexed with a superantigenQ27733857
The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine proteaseQ27734852
Dual conformations of a T cell receptor V alpha homodimer: implications for variability in V alpha V beta domain associationQ27739760
The three-dimensional structure of a T-cell antigen receptor V alpha V beta heterodimer reveals a novel arrangement of the V beta domainQ27741302
Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigenQ27748865
Analysis of binding interactions in an idiotope-antiidiotope protein-protein complex by double mutant cyclesQ30426199
Atomic structure of an alphabeta T cell receptor (TCR) heterodimer in complex with an anti-TCR fab fragment derived from a mitogenic antibodyQ33887941
T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigensQ36363962
Evidence for a functional interaction between the beta chain of major histocompatibility complex class II and the T cell receptor alpha chain during recognition of a bacterial superantigenQ36363993
Superantigen binding to a T cell receptor beta chain of known three-dimensional structureQ36365631
Different superantigens interact with distinct sites in the Vbeta domain of a single T cell receptorQ36366515
Highly biased CDR3 usage in restricted sets of beta chain variable regions during viral superantigen 9 responseQ36400117
Mycoplasma superantigen is a CDR3-dependent ligand for the T cell antigen receptorQ36400240
A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II.Q36400491
Kinetic discrimination in T-cell activationQ37715642
A mutational analysis of the binding of two different proteins to the same antibodyQ38355029
T-cell activation by superantigensQ40626305
Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biologyQ41039639
The structure of the T cell antigen receptorQ41039749
T-cell-receptor affinity and thymocyte positive selectionQ41192128
Serial triggering of many T-cell receptors by a few peptide-MHC complexesQ41346263
T-cell receptor structure and TCR complexesQ41685092
Ligand-specific oligomerization of T-cell receptor moleculesQ46536198
A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetesQ48047077
Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiologyQ59054467
Crystal structure of staphylococcal enterotoxin B, a superantigenQ59078216
P921main subjectsuperantigenQ772950
P304page(s)177-186
P577publication date1998-06-01
P1433published inImmunological ReviewsQ15724582
P1476titleStructure-function studies of T-cell receptor-superantigen interactions
P478volume163

Reverse relations

cites work (P2860)
Q37718638Community-acquired methicillin-resistant Staphylococcus aureus: community transmission, pathogenesis, and drug resistance
Q39301452FDA-approved immunosuppressants targeting staphylococcal superantigens: mechanisms and insights
Q57266797Genuine Monovalent Ligands of TrkA Nerve Growth Factor Receptors Reveal a Novel Pharmacological Mechanism of Action
Q35654266Healthcare- and Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) and Fatal Pneumonia with Pediatric Deaths in Krasnoyarsk, Siberian Russia: Unique MRSA's Multiple Virulence Factors, Genome, and Stepwise Evolution
Q36905471High-Resolution Longitudinal Study of HIV-1 Env Vaccine-Elicited B Cell Responses to the Virus Primary Receptor Binding Site Reveals Affinity Maturation and Clonal Persistence.
Q42677458Influence of histidine beta81 of HLA-DR101 on peptide binding and presentation to T-cell receptor
Q33987727Microbial superantigens: from structure to function
Q30369011Overview of protein folds in the immune system.
Q47314227Peptide antagonists of superantigen toxins
Q41363383Secondary mechanisms of diversification in the human antibody repertoire.
Q42705126Specific inhibitory action of anisodamine against a staphylococcal superantigenic toxin, toxic shock syndrome toxin 1 (TSST-1), leading to down-regulation of cytokine production and blocking of TSST-1 toxicity in mice
Q33890232Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors
Q40814543Superantigen recognition by gammadelta T cells: SEA recognition site for human Vgamma2 T cell receptors
Q34123105Superantigens: microbial agents that corrupt immunity
Q27639245The Three-dimensional structure of a superantigen-like protein, SET3, from a pathogenicity island of the Staphylococcus aureus genome
Q47859097Transcriptional response signature of human lymphoid cells to staphylococcal enterotoxin B.
Q36759362What's new in the aetiopathogenesis of vasculitis?